Next 10 |
2024-03-28 13:46:05 ET More on Invesco S&P 500 Equal Weight ETF: RSP: Equal Weighting The S&P 500 To Minimize Magnificent Seven Exposure Is Not Optimal RSP: I Firmly Believe In An Allocation To Equal-Weight At This Juncture RSP: Happy 2024! Don't Make Decisio...
Roivant Sciences Set to Join S&P MidCap 400; Sunrun to Join S&P SmallCap 600 Roivant Sciences Set to Join S&P MidCap 400; Sunrun to Join S&P SmallCap 600 PR Newswire NEW YORK , March 26, 2024 /PRNewswire/ -- Roivant Sciences Ltd (NASD:ROI...
2024-03-18 15:52:57 ET Summary Roivant Sciences Ltd. has seen a slight gain of 10% in its stock over the past 10 months, since my "buy" recommendation last May. The company has a differentiated drug development pipeline targeting multi-billion dollar indications, thanks to its uni...
CNS Pharmaceuticals recently appointed Amy Mahery, a biotech commercialization leader, to its Board of Directors Ms. Mahery brings over 20 years’ experience, having worked with small and large companies, and has held diverse commercial leadership roles in the U.S. and globally The comp...
2024-03-06 17:09:23 ET Summary Baker Brothers' 13F portfolio value decreased from $17.35B to $8.79B. The largest five stakes in the portfolio are Incyte, BeiGene, ACADIA Pharma, Madrigal Pharma, and Rhythm Pharma. New stakes include Cerevel Therapeutics, while stake disposals ...
2024-02-13 12:02:07 ET Roivant Sciences Ltd. (ROIV) Q3 2023 Results Conference Call February 13, 2024 08:00 AM ET Company Participants Stephanie Lee - Vice President, Special Projects Matt Gline - Chief Executive Officer Mayukh Sukhatme - President and Chief Inve...
2024-02-13 07:06:27 ET More on Roivant Sciences Chris DeMuth Sure Likes Uranium And SHF Holdings + 3 Litigation Ideas Roivant Sciences: Why Its 'Vant' Biotech Model Is A Buy Roivant Sciences Q3 2024 Earnings Preview Arbutus Biopharma gains after Markman heari...
BASEL, Switzerland and LONDON and NEW YORK, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today reported its financial results for the third quarter ended December 31, 2023, and provided a business update. Roivant completed the sale of Telavant to Roche for $7.1B with an additi...
ESSA Pharma Inc. (EPIX) is expected to report $-0.17 for Q1 2024 QuidelOrtho Corp Com (QDEL) is expected to report $2.01 for Q4 2023 FaZe Holdings Inc. (FAZE) is expected to report for Q4 2023 Portsmouth Square, Inc. (PRSI) is expected to report for Q2 2024 Similarweb Ltd. (SMWB) ...
2024-02-12 12:44:03 ET More on Roivant Sciences Chris DeMuth Sure Likes Uranium And SHF Holdings + 3 Litigation Ideas Roivant Sciences: Why Its 'Vant' Biotech Model Is A Buy Arbutus Biopharma gains after Markman hearing on Thursday in Moderna dispute Vivek Ra...
News, Short Squeeze, Breakout and More Instantly...
Roivant Sciences Ltd. Company Name:
ROIV Stock Symbol:
NASDAQ Market:
Roivant Sciences Set to Join S&P MidCap 400; Sunrun to Join S&P SmallCap 600 Roivant Sciences Set to Join S&P MidCap 400; Sunrun to Join S&P SmallCap 600 PR Newswire NEW YORK , March 26, 2024 /PRNewswire/ -- Roivant Sciences Ltd (NASD:ROI...
CNS Pharmaceuticals recently appointed Amy Mahery, a biotech commercialization leader, to its Board of Directors Ms. Mahery brings over 20 years’ experience, having worked with small and large companies, and has held diverse commercial leadership roles in the U.S. and globally The comp...
What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future g...